YCQ

1alpha,3beta-dihydroxy-14-methyl-23-oxo-5beta,14beta,17alpha-9,19-cycloergost-24(28)-ene-4alpha-carboxylic acid

Created:	2023-06-13
Last modified:	2024-12-18

Find Related PDB Entry
1 entries where YCQ is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	81
Chiral Atom Count	11
Bond Count	85
Aromatic Bond Count	0

2D diagram of YCQ

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	1alpha,3beta-dihydroxy-14-methyl-23-oxo-5beta,14beta,17alpha-9,19-cycloergost-24(28)-ene-4alpha-carboxylic acid
Systematic Name (OpenEye OEToolkits)	n/a
Formula	C₃₀ H₄₆ O₅
Molecular Weight	486.683
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	CC(C)C(=C)C(=O)CC(C)C1CCC2(C)C3CCC4C(C(=O)O)C(O)CC(O)C44CC34CCC12C
SMILES	CACTVS	3.385	CC(C)C(=C)C(=O)C[CH](C)[CH]1CC[C]2(C)[CH]3CC[CH]4[CH]([CH](O)C[CH](O)[C]45C[C]35CC[C]12C)C(O)=O
SMILES	OpenEye OEToolkits	2.0.7	CC(C)C(=C)C(=O)CC(C)C1CCC2(C1(CCC34C2CCC5C3(C4)C(CC(C5C(=O)O)O)O)C)C
Canonical SMILES	CACTVS	3.385	CC(C)C(=C)C(=O)C[C@@H](C)[C@H]1CC[C@@]2(C)[C@@H]3CC[C@H]4[C@@H]([C@H](O)C[C@H](O)[C@@]45C[C@@]35CC[C@]12C)C(O)=O
Canonical SMILES	OpenEye OEToolkits	2.0.7	C[C@H](CC(=O)C(=C)C(C)C)[C@H]1CC[C@@]2([C@@]1(CC[C@]34[C@H]2CC[C@@H]5[C@]3(C4)[C@H](C[C@H]([C@H]5C(=O)O)O)O)C)C
InChI	InChI	1.06	InChI=1S/C30H46O5/c1-16(2)18(4)21(31)13-17(3)19-9-10-28(6)23-8-7-20-25(26(34)35)22(32)14-24(33)30(20)15-29(23,30)12-11-27(19,28)5/h16-17,19-20,22-25,32-33H,4,7-15H2,1-3,5-6H3,(H,34,35)/t17?,19-,20?,22?,23+,24?,25?,27-,28+,29+,30-/m1/s1
InChIKey	InChI	1.06	ZWHOUWGCSQPCER-QWBVHANISA-N

Related Resource References

Resource Name	Reference
PubChem	172635942

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.